Hanson & Doremus Investment Management Increases Holdings in Cigna Group $CI

Hanson & Doremus Investment Management grew its holdings in shares of Cigna Group (NYSE:CI) by 88.3% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,578 shares of the health services provider’s stock after buying an additional 740 shares during the period. Hanson & Doremus Investment Management’s holdings in Cigna Group were worth $522,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently bought and sold shares of the company. Flaharty Asset Management LLC purchased a new stake in Cigna Group during the 1st quarter worth about $28,000. 1248 Management LLC purchased a new stake in Cigna Group during the 1st quarter worth about $29,000. Activest Wealth Management increased its position in shares of Cigna Group by 360.0% during the first quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock worth $30,000 after purchasing an additional 72 shares in the last quarter. Retirement Wealth Solutions LLC increased its position in shares of Cigna Group by 74.1% during the second quarter. Retirement Wealth Solutions LLC now owns 101 shares of the health services provider’s stock worth $33,000 after purchasing an additional 43 shares in the last quarter. Finally, Saudi Central Bank acquired a new stake in shares of Cigna Group during the first quarter worth about $36,000. 86.99% of the stock is owned by hedge funds and other institutional investors.

Cigna Group Stock Up 0.7%

CI opened at $286.04 on Monday. The business has a 50 day moving average price of $292.71 and a two-hundred day moving average price of $310.49. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.65. The company has a market cap of $76.35 billion, a PE ratio of 15.61, a P/E/G ratio of 0.84 and a beta of 0.48. Cigna Group has a 52 week low of $256.89 and a 52 week high of $358.88.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, beating the consensus estimate of $7.15 by $0.05. The firm had revenue of $67.13 billion during the quarter, compared to the consensus estimate of $62.61 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The firm’s revenue was up 11.0% compared to the same quarter last year. During the same period in the prior year, the business earned $6.72 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, research analysts anticipate that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 18th. Shareholders of record on Thursday, September 4th were given a dividend of $1.51 per share. The ex-dividend date was Thursday, September 4th. This represents a $6.04 annualized dividend and a yield of 2.1%. Cigna Group’s payout ratio is presently 32.97%.

Insider Transactions at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of the business’s stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the transaction, the insider owned 25,648 shares in the company, valued at approximately $7,694,400. The trade was a 52.66% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 0.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on CI shares. Truist Financial set a $375.00 target price on Cigna Group in a research report on Tuesday, September 2nd. Cantor Fitzgerald reiterated an “overweight” rating and set a $365.00 target price on shares of Cigna Group in a research report on Tuesday, August 26th. Wall Street Zen upgraded Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday, September 13th. Royal Bank Of Canada reiterated an “outperform” rating and set a $371.00 target price on shares of Cigna Group in a research report on Thursday, June 26th. Finally, Barclays lifted their target price on Cigna Group from $354.00 to $383.00 and gave the stock an “overweight” rating in a research report on Thursday, September 4th. Two equities research analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $371.81.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.